Foxo Technologies signs non-binding agreement to acquire Vector Biosource
FOXO Technologies (FOXO) has signed a non-binding agreement to acquire Vector Biosource. Vector is an information and biospecimen sourcing ...
FOXO TECHNOLOGIES INC. ANNOUNCES EXECUTION OF A NON BINDING AGREEMENT TO ACQUIRE VECTOR BIOSOURCE INC.
FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), announces that it has signed a non-binding agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information and biospecimen ...
Pharmaceutical Technology10d
Artificial intelligence is making clinical supply chains more efficient and more sustainable: here’s how
The potential applications of artificial intelligence (AI) in biopharmaceuticals appear wide-ranging and transformative.
Talk Business & Politics14d
UAMS Rockefeller Cancer Institute scientist lands $1.9 million to study air pollution, breast cancer
A researcher at the Winthrop P. Rockefeller Cancer Institute at the University of Arkansas for Medical Sciences (UAMS) has received a $1.9 million grant from the National Institute of ...
Healio22d
Morehouse cancer research expert named American College of Health Data Management fellow
She has led large-scale biospecimen repositories, facilitated investigator-sponsored cancer research and enhanced patient education and engagement in underserved communities, according to the ...
Taiwan News24d
LabConnect and Australian Clinical Labs' Specialised Trials Announce Strategic Partnership in Australia and Asia Pacific Region
LabConnect scientific experts support pre-clinical and clinical studies with scientific project management, bioanalytical and biospecimen management, biomarker strategy and logistics solutions.
Yahoo Finance2d
Predictive Oncology Inc. (POAI)
Enables AI platform to model and predict patient outcomes on historical samples Global biospecimen market valued at $4.4 billion in 2023, expected to grow at an annual CAGR of more than 13% ...